阿斯利康任命内部人士为美国生物制药部门主管

Core Viewpoint - AstraZeneca has appointed Rick Suarez, an internal candidate, as the head of its U.S. biopharmaceutical division to lead a $50 billion investment plan in research and production in the U.S. [1] Group 1 - The investment plan includes the construction of a $4.5 billion manufacturing facility in Virginia, marking AstraZeneca's largest single production investment globally [1]